4-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-(4-fluorobenzo[d]thiazol-2-yl)benzamide结构式
|
常用名 | 4-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-(4-fluorobenzo[d]thiazol-2-yl)benzamide | 英文名 | 4-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-(4-fluorobenzo[d]thiazol-2-yl)benzamide |
|---|---|---|---|---|
| CAS号 | 862807-25-8 | 分子量 | 467.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C23H18FN3O3S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 4-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-(4-fluorobenzo[d]thiazol-2-yl)benzamide |
|---|
| 分子式 | C23H18FN3O3S2 |
|---|---|
| 分子量 | 467.5 |
| InChIKey | CVHCVSYUXKZDQV-UHFFFAOYSA-N |
| SMILES | C1CN(CC2=CC=CC=C21)S(=O)(=O)C3=CC=C(C=C3)C(=O)NC4=NC5=C(C=CC=C5S4)F |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|